CONSOLI, MARIA LETIZIA
CONSOLI, MARIA LETIZIA
BIOMEDICINA CLINICA E MOLECOLARE (attivo dal 09/07/2010 al 30/10/2014)
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res
2006-01-01 Tirro, E; Consoli, Ml; Massimino, M; Manzella, L; Frasca, F; Sciacca, L; Vicari, L; Stassi, G; Messina, L.; Messina, A; Vigneri, P
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report
2019-01-01 Massimino, Michele; Stella, Stefania; Tirrò, Elena; Consoli, Maria Letizia; Pennisi, Maria Stella; Puma, Adriana; Vitale, Silvia Rita; Romano, Chiara; Zammit, Valentina; Stagno, Fabio; DI Raimondo, Francesco; Manzella, Livia
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22)
2019-01-01 Tirrò, Elena; Massimino, Michele; Stella, Stefania; Zammit, Valentina; Consoli, Maria Letizia; Pennisi, Maria Stella; Vitale, SILVIA RITA; Romano, Chiara; Pirosa, Maria Cristina; Martino, Enrica; DI GREGORIO, Sandra; Puma, Adriana; DI Raimondo, Franscesco; Manzella, Livia; Stagno, Fabio
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS
file da validare2015-01-01 Romano, A; Parrinello, Nl; Consoli, MARIA LETIZIA; Forte, S; Marchionni, L; Conticello, CONCETTA MARIA SEBASTIANA; Corso, Emanuele Antonio; Pompa, A; Noonan, K; Borrello, I; Di Raimondo, F
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report
2020-01-01 Manzella, Livia; Tirrò, Elena; Vitale, Silvia Rita; Puma, Adriana; Consoli, Maria Letizia; Tambè, Loredana; Pennisi, Maria Stella; DI Gregorio, Sandra; Romano, Chiara; Tomarchio, Cristina; DI Raimondo, Francesco; Stagno, Fabio
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report
2019-01-01 Massimino, M.; Stella, S.; Tirro, E.; Consoli, M. L.; Pennisi, M. S.; Puma, A.; Vitale, S. R.; Romano, C.; Zammit, V.; Stagno, F.; Di Raimondo, F.; Manzella, L.
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients
2020-01-01 Markovic, U.; Bulla, A.; Leotta, S.; Stella, S.; Consoli, M. L.; Tambe, L.; Conticello, C.; Raimondo, F. D. I.; Stagno, F.
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents
2017-01-01 Romano, Alessandra; Parrinello, Nunziatina Laura; Cerchione, Claudio; Consoli, Maria Letizia; Parisi, Marina; Calafiore, Valeria; Martino, Enrica; Conticello, Concetta; Raimondo, Francesco Di; Palumbo, Giuseppe Alberto
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res | 1-gen-2006 | Tirro, E; Consoli, Ml; Massimino, M; Manzella, L; Frasca, F; Sciacca, L; Vicari, L; Stassi, G; Messina, L.; Messina, A; Vigneri, P | |
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report | 1-gen-2019 | Massimino, Michele; Stella, Stefania; Tirrò, Elena; Consoli, Maria Letizia; Pennisi, Maria Stella; Puma, Adriana; Vitale, Silvia Rita; Romano, Chiara; Zammit, Valentina; Stagno, Fabio; DI Raimondo, Francesco; Manzella, Livia | |
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) | 1-gen-2019 | Tirrò, Elena; Massimino, Michele; Stella, Stefania; Zammit, Valentina; Consoli, Maria Letizia; Pennisi, Maria Stella; Vitale, SILVIA RITA; Romano, Chiara; Pirosa, Maria Cristina; Martino, Enrica; DI GREGORIO, Sandra; Puma, Adriana; DI Raimondo, Franscesco; Manzella, Livia; Stagno, Fabio | |
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS | 1-gen-2015 | Romano, A; Parrinello, Nl; Consoli, MARIA LETIZIA; Forte, S; Marchionni, L; Conticello, CONCETTA MARIA SEBASTIANA; Corso, Emanuele Antonio; Pompa, A; Noonan, K; Borrello, I; Di Raimondo, F | file da validare |
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report | 1-gen-2020 | Manzella, Livia; Tirrò, Elena; Vitale, Silvia Rita; Puma, Adriana; Consoli, Maria Letizia; Tambè, Loredana; Pennisi, Maria Stella; DI Gregorio, Sandra; Romano, Chiara; Tomarchio, Cristina; DI Raimondo, Francesco; Stagno, Fabio | |
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report | 1-gen-2019 | Massimino, M.; Stella, S.; Tirro, E.; Consoli, M. L.; Pennisi, M. S.; Puma, A.; Vitale, S. R.; Romano, C.; Zammit, V.; Stagno, F.; Di Raimondo, F.; Manzella, L. | |
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients | 1-gen-2020 | Markovic, U.; Bulla, A.; Leotta, S.; Stella, S.; Consoli, M. L.; Tambe, L.; Conticello, C.; Raimondo, F. D. I.; Stagno, F. | |
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents | 1-gen-2017 | Romano, Alessandra; Parrinello, Nunziatina Laura; Cerchione, Claudio; Consoli, Maria Letizia; Parisi, Marina; Calafiore, Valeria; Martino, Enrica; Conticello, Concetta; Raimondo, Francesco Di; Palumbo, Giuseppe Alberto |